# Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus

> **NCT05007977** · PHASE1 · TERMINATED · sponsor: **Zucara Therapeutics Inc.** · enrollment: 24 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** ZT-01 low dose
- **DRUG:** ZT-01 high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05007977
- **Lead sponsor:** Zucara Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-08
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-18
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** The study was completed following review of the assumptions underlying the power calculation and it was deemed that enough subjects had been recruited to complete enrollment
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007977, "Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05007977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*